sodium pentobarbital dose - An Overview
sodium pentobarbital dose - An Overview
Blog Article
pentobarbital will decrease the extent or effect of saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
pentobarbital will lower the level or effect of mavacamten by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Watch Closely (1)pentobarbital will decrease the level or effect of mifepristone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. CYP3A4 inducers have not been studied, coadministration not recommended by maker
pentobarbital will minimize the extent or effect of prednisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will increase toxicity of buprenorphine, extensive-performing injection by pharmacodynamic synergism. Modify Therapy/Keep an eye on Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants increases hazard of adverse reactions together with overdose, respiratory melancholy, and death. Cessation of benzodiazepines or other CNS depressants is most well-liked typically.
pentobarbital will decrease the level or effect of meloxicam by impacting hepatic enzyme CYP2C9/ten metabolism. Insignificant/Importance Unknown.
pentobarbital will decrease the level or effect of methadone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will lessen the extent or effect of etravirine by influencing hepatic enzyme CYP2C9/10 check here metabolism. Use Warning/Keep an eye on.
pentobarbital will decrease the level or effect of pitolisant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Pitolisant exposure is reduced by 50% if coadministered with sturdy CYP3A4 inducers.
pentobarbital and daridorexant each raise sedation. Modify Therapy/Check Carefully. Coadministration raises hazard of CNS depression, which can cause additive impairment of psychomotor overall performance and bring about daytime impairment.
pentobarbital will reduce the level or effect of losartan by impacting hepatic enzyme CYP2C9/ten metabolism. Insignificant/Importance Unidentified.
pentobarbital will enhance the level or effect of ivosidenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration of ivosidenib with strong CYP3A4 inducers decreased ivosidenib plasma concentrations.
pentobarbital will reduce the extent or effect of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic effect of elbasvir/grazoprevir could be lessened if coadministered with robust CYP3A inducers which is therefore contraindicated.
pentobarbital will lower the extent or effect of midazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.